Related Experiment Video
Updated: May 2, 2026

A Preclinical Controlled Cortical Impact Model for Traumatic Hemorrhage Contusion and Neuroinflammation
Published on: June 10, 2020
Unraveling the complexity of microglial responses in traumatic brain and spinal cord injury
Rebecca J Henry1, David J Loane2
1Department of Pharmacology, School of Biomolecular and Biomedical Science, University College Dublin, Dublin, Ireland.
Abstract:
Microglia, the resident innate immune cells of the central nervous system (CNS), play an important role in neuroimmune signaling, neuroprotection, and neuroinflammation. In the healthy CNS, microglia adopt a surveillant and antiinflammatory phenotype characterized by a ramified scanning morphology that maintains CNS homeostasis. In response to acquired insults, such as traumatic brain injury (TBI) or spinal cord injury (SCI), microglia undergo a dramatic morphologic and functional switch to that of a reactive state. This microglial switch is initially protective and supports the return of the injured tissue to a physiologic homeostatic state. However, there is now a significant body of evidence that both TBI and SCI can result in a chronic state of microglial activation, which contributes to neurodegeneration and impairments in long-term neurologic outcomes in humans and animal models. In this review, we discuss the complex role of microglia in the pathophysiology of TBI and SCI, and recent advancements in knowledge of microglial phenotypic states in the injured CNS. Furthermore, we highlight novel therapeutic strategies targeting chronic microglial responses in experimental models and discuss how they may ultimately be translated to the clinic for human brain and SCI.
Insights
Microglia in the central nervous system (CNS) can be protective after injury but chronic activation contributes to neurodegeneration. Targeting this chronic microglial response may offer new therapies for brain and spinal cord injuries.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Microglia are the primary immune cells of the central nervous system (CNS).
- In healthy CNS, microglia maintain homeostasis with an anti-inflammatory phenotype.
- CNS injuries like traumatic brain injury (TBI) and spinal cord injury (SCI) trigger microglial activation.
Purpose of the Study:
- To review the dual role of microglia in TBI and SCI pathophysiology.
- To discuss evolving knowledge of microglial phenotypes post-injury.
- To highlight therapeutic strategies targeting chronic microglial activation.
Main Methods:
- Review of existing literature on microglial roles in CNS injury.
- Analysis of studies on microglial phenotypic states.
- Examination of therapeutic interventions in preclinical models.
Main Results:
- Microglial activation is initially protective but can become chronically detrimental.
- Chronic microglial activation contributes to neurodegeneration and poor outcomes after TBI and SCI.
- Distinct microglial phenotypic states exist in the injured CNS.
Conclusions:
- Microglia have a complex, context-dependent role in CNS injury.
- Understanding microglial phenotypes is crucial for developing effective treatments.
- Targeting chronic microglial activation holds promise for treating TBI and SCI.
More Related Videos
07:21Systems Analysis of the Neuroinflammatory and Hemodynamic Response to Traumatic Brain Injury
Published on: May 27, 2022
08:27Development of an Uncomplicated Mild Traumatic Brain Injury Model Modified by Weight-Drop Method and Evidenced by Magnetic Resonance Imaging
Published on: April 11, 2025
Related Concept Videos
Hemorrhagic Stroke ll: Pathophysiology
Bacterial Meningitis II: Pathophysiology
Traumatic Brain Injury l: Introduction
Spinal Cord Injury ll: Pathophysiology
Cerebral Edema ll: Pathophysiology
Secondary Spinal Cord Injury llI: Pathophysiology